Versant Capital Management, Inc - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 206 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q4 2023$398
-62.0%
166
-46.1%
0.00%
Q3 2023$1,047
-53.8%
3080.0%0.00%
-100.0%
Q2 2023$2,264
-41.5%
308
-18.1%
0.00%0.0%
Q1 2023$3,867
-50.1%
376
-42.7%
0.00%
-66.7%
Q4 2022$7,747
+158.2%
656
+328.8%
0.00%
+200.0%
Q3 2022$3,000
-40.0%
153
+3.4%
0.00%
-50.0%
Q2 2022$5,000
-28.6%
148
-12.4%
0.00%0.0%
Q1 2022$7,000
-78.1%
169
-59.2%
0.00%
-86.7%
Q2 2020$32,000
+39.1%
414
+1.2%
0.02%
+25.0%
Q1 2020$23,000
+64.3%
409
+47.1%
0.01%
+71.4%
Q4 2019$14,000
+16.7%
278
+19.8%
0.01%
+16.7%
Q3 2019$12,000
+140.0%
232
+101.7%
0.01%
+200.0%
Q2 2019$5,000
-82.1%
115
-61.4%
0.00%
-66.7%
Q1 2019$28,000
+75.0%
298
+6.0%
0.01%
-14.3%
Q4 2018$16,000
-11.1%
281
-0.7%
0.01%0.0%
Q3 2018$18,000
+12.5%
283
-13.5%
0.01%0.0%
Q2 2018$16,000
-5.9%
3270.0%0.01%0.0%
Q1 2018$17,000
+6.2%
327
-6.8%
0.01%
+16.7%
Q4 2017$16,000
+14.3%
351
+1.2%
0.01%
-25.0%
Q3 2017$14,000
+27.3%
347
+5.2%
0.01%
+33.3%
Q2 2017$11,000
+57.1%
330
+28.9%
0.01%
+50.0%
Q1 2017$7,000
-12.5%
256
+3.6%
0.00%
-20.0%
Q4 2016$8,0000.0%247
-8.5%
0.01%0.0%
Q3 2016$8,000
+14.3%
2700.0%0.01%
+25.0%
Q2 2016$7,000
-22.2%
270
-0.7%
0.00%
-20.0%
Q1 2016$9,000
-25.0%
272
-13.4%
0.01%
-37.5%
Q4 2015$12,0003140.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2015
NameSharesValueWeighting ↓
AIMZ Investment Advisors, LLC 52,590$6210.29%
Values First Advisors, Inc. 33,942$400,8580.28%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 91,000$1,075,0000.23%
SummerHaven Investment Management, LLC 25,347$299,3480.18%
PALISADE CAPITAL MANAGEMENT, LP 501,672$5,924,7460.16%
CORNERCAP INVESTMENT COUNSEL INC 67,457$796,6670.14%
Edgestream Partners, L.P. 94,553$1,116,6710.13%
OCCUDO QUANTITATIVE STRATEGIES LP 86,569$1,022,3800.12%
DUALITY ADVISERS, LP 77,298$912,8890.10%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,253,042$14,798,4270.10%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders